Cipla completes Phase-3 clinical study for generic version of GSK Advair Diskus Medical Dialogues Bureau5 April 2020 9:11 AM GMTMumbai: Cipla Limited has announced the successful completion of the Phase-3 clinical end-point study for fluticasone propionate and salmeterol inhalat...
EMA accepts GSK filing for Trelegy Ellipta use in adults with asthma Medical Dialogues Bureau4 March 2020 4:45 AM GMTonce-daily single inhaler triple therapy available for asthma and COPD if approved